Group One Trading
IMNM icon

Group One Trading’s Immunome IMNM Stock Holding History

Group One Trading’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-22,999
Closed -$512K – 8130
2025
Q4 		$494K Buy
22,999
+18,210
+380% +$320K ﹤0.01% 3529
2025
Q3 		$56.1K Buy
4,789
+1,743
+57% +$17.3K ﹤0.01% 5860
2025
Q2 		$28.3K Buy
3,046
+1,346
+79% +$11K ﹤0.01% 6032
2025
Q1 		$11.4K Buy
+1,700
New +$16.3K ﹤0.01% 6170
2024
Q4 		– Sell
-7,616
Closed -$92K – 7590
2024
Q3 		$111K Buy
+7,616
New +$108K ﹤0.01% 4086
2023
Q3 		– Sell
-7,705
Closed -$56.6K – 7932
2023
Q2 		$60.9K Hold
7,705
– – ﹤0.01% 5105
2023
Q1 		$38.4K Buy
7,705
+5,529
+254% +$27K ﹤0.01% 5045
2022
Q4 		$4.79K Sell
2,176
-100
-4% -$403 ﹤0.01% 6361
2022
Q3 		$10K Buy
2,276
+2,228
+4,642% +$10.4K ﹤0.01% 6493
2022
Q2 		$0 Buy
+48
New +$175 ﹤0.01% 8122

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Group One Trading's IMNM Position: Q1 2026 in Review

Group One Trading sold out of Immunome (IMNM) in Q1 2026, closing a stake of 22,999 shares — an estimated $512K sold.

Group One Trading first reported a position in IMNM in Q2 2022 and held it in 10 quarters. The position peaked at $494K in Q4 2025. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Group One Trading reported no remaining Immunome position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 22,999 Immunome shares in Q1 2026, an estimated $512K.
  • Group One Trading first reported a position in Immunome in Q2 2022 and held it in 10 quarters.
  • Group One Trading's Immunome position peaked at $494K in Q4 2025.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.